drugset / Trial / NCT07038330

DOSE FINDING PROSPECTIVE ANALYSIS AFTER HEART SURGERY for Sucrosomial Iron

NCT07038330

Phase 4 Not yet recruiting 150 enrolled Cardiochirurgia E.H.
RandomizedParallel-groupOpen-labelTreatment

Summary

Randomization to different doses of Sucrosomial Iron for one moth after discharge to rehab after heart surgery to assess if more iron grants a faster recovery or not

Timeline

Start
2025-06-23
Primary completion
2025-10-31
Completion
2025-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Sucrosomial Iron Unknown 30 mg Oral
Subject Sucrosomial Iron Unknown 60 mg Oral
Subject Sucrosomial Iron Unknown 120 mg Oral

Indications